ENOS anticorps
(2 références)Aperçu rapide pour ENOS anticorps (ABIN969097)
Antigène
Voir toutes ENOS (NOS3) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- eNOS Antibody
-
Purification
- Ascitic fluid
-
Immunogène
- Purified recombinant fragment of human eNOS expressed in E. Coli.
-
Isotype
- IgG1
-
-
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (pSer1177) antibody
NOS3 Reactivité: Humain, Rat, Souris WB, ELISA, IHC, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (C-Term) antibodyNOS3 Reactivité: Humain, Rat, Souris WB, ELISA, IHC, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1105-1202) antibodyNOS3 Reactivité: Humain, Rat, Souris WB, ELISA, IF (cc), IF (p), FACS, IHC (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1156-1183) antibodyNOS3 Reactivité: Humain WB, IF, FACS Hôte: Lapin Polyclonal RB29786 unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 48-75), (N-Term) antibodyNOS3 Reactivité: Humain IF, FACS, IHC (p) Hôte: Lapin Polyclonal RB18211 unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (pSer1177) antibodyNOS3 Reactivité: Humain, Rat, Souris WB, ELISA, IF (cc), IF (p), FACS, IHC (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1-120) antibodyNOS3 Reactivité: Humain WB, IF Hôte: Lapin Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1156-1183) antibodyNOS3 Reactivité: Humain WB, ELISA, IF, FACS Hôte: Lapin Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 756-888) antibodyNOS3 Reactivité: Humain WB, IHC, ICC, IP Hôte: Lapin Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 61-160) antibodyNOS3 Reactivité: Humain WB, ELISA, PLA Hôte: Souris Monoclonal 1D12 unconjugated
-
-
Indications d'application
- ELISA: 1/10000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Ascitic fluid containing 0.03 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "Genetic polymorphisms and haplotypes of eNOS in breast cancer." dans: Breast cancer research and treatment, Vol. 109, Issue 1, pp. 181-2, (2008) (PubMed).
: "Reduced expression of endothelial and inducible nitric oxide synthase in a multidrug resistant variant of the MCF-7 human breast cancer cell line." dans: Oncology reports, Vol. 12, Issue 5, pp. 1007-11, (2004) (PubMed).
-
-
- ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
-
Autre désignation
- eNOS
-
Sujet
- Endothelial nitric-oxide synthase (eNOS), also known as NOS3, it is an important enzyme in the cardiovascular system. It is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm.
-
Poids moléculaire
- 133 kDa
-
ID gène
- 4846
-
UniProt
- P29474
-
Pathways
- ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Antigène
-
